Assoc. Prof. Umut Dişel is a medical oncologist with a strong clinical and academic background. He earned his medical oncology qualification in 2017 and has since combined patient care, teaching, and research. In 2018 he joined Acıbadem Health Group, where he provides comprehensive oncology care and participates in multidisciplinary treatment planning. He is an active member of the Medical Oncology Society and the Anatolian Medical Oncology Association, contributing to professional development and collaboration within the oncology community. Known for a patient-centered approach, he focuses on evidence-based treatments and clear communication to support patients and families through diagnosis and therapy.
Education
- 2017 Medical Oncology / Associate Professor
- 2005 Cukurova University Faculty of Medicine Medical Oncology
- 2001 Çukurova University Faculty of Medicine Internal Medicine
- 1995 Cukurova University Faculty of Medicine
Experience
- 2018 Acibadem Health Group
Memberships
- Medical Oncology Society
- Anatolian Medical Oncology Association
Publications
- Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors
Supportive Care in Cancer, 21(4), 1131-1135., Number of Citation: 2, Doi: 10.1007/s00520-012-1636-z ABALI HÜSEYİN,SEZER AHMET.Oğuzkurt Levent.GUREL KAMİL,Özkan Uğur.Beşen Ali Ayberk, SÜMBÜL AHMET TANER,KÖSE FATİH,DİŞEL UMUT - Acute infusion reactions to chemotherapeutic drugs: A single institute experience.
JOURNAL OF BALKAN UNION OF ONCOLOGY, 18(1), 261-267., Number of Citation: 1, (Control No: 1606723) MUALLAOGLU SADIK.DİŞEL UMUT.MERTSOYLU HÜSEYİN,BESEN ALI AYBERK,KARADENİZ CEMİLE, SÜMBÜL AHMET TANER.ABALI HÜSEYİN,ÖZYILKAN ÖZGÜR - Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience
European Journal of Radiology, 81(8), 1724-1727., Number of Citation: 3, Doi: 10.1016/j.ejrad.2011.04.056 KÖSE FATİH,OGUZKURT LEVENT.BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET, Karadeniz Cemile.DİŞEL UMUT.MERTSOYLU HÜSEYİN,ÖZYILKAN ÖZGÜR - A case report of bevacizumab-related osteonecrosis of the jaw: Old problem, new culprit.
Oral Oncology, 48(2), 2-3., Number of Citation: 13, Doi: 10.1016/j.oraloncology.2011.07.030, DİŞEL UMUT.Beşen Ali Ayberk.Beşen Ali Ayberk.ÖZYILKAN ÖZGÜR.Er Efsun,CANPOLAT EMİNE TUBA - Secondary malignancy after imatinib therapy: eight cases and review of the literature
Leukemia & Lymphoma, 53(9), 1706¬1708., Number of Citation: 7, Doi: 10.3109/10428194.2012.666545 BOZKURT DUMAN BERNA.PAYDAŞ SEMRA.DİŞEL UMUT BESEN AYBERK,GÜRKAN EMEL - Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer:
The Başkent University experience. Asian Pacific Journal of Cancer Prevention, 12(5), 1185-1188., Number of Citations: 1 KÖSE FATİH,BESEN ALI AYBERK.SÜMBÜL AHMET TANER,SEZER AHMET.KARADENIZ CEMİLE, DİŞEL UMUT.ALTUNDAG ÖZDEN,ÖZYILKAN ÖZGÜR - Hypertension Associated With Angiogoenesis Inhibitors: What Do Oncologists Really Do in Daily Routine? A Small Survey
The Journal of Clinical Hypertension, 13(11), 863-863., Citation: 0, Doi: 10.1111 /j.1751-7176.2011.00526. DİŞEL UMUT.ABALI HÜSEYİN.SÜMBÜL AHMET TANER.ÖZYILKAN ÖZGÜR - Letter to the editor. Supportive Care in Cancer
18(6), 657-658., Citation: 0, Doi: 10.1007/s00520-010- 0842-9, KÖSE FATİH.Abali Huseyin.Ayberk Besen,DİŞEL UM UT, HAYRAN KADİR MUTLU - Unilateral hand-foot syndrome: an extraordinary side effect of capecitabine
Cutaneous and Ocular Toxicology, 29(2), 140-142., Number of Citation: 5, Doi: 10.3109/15569521003699585 DİŞEL UMUT.GURKUT OZLEM.ABALI HÜSEYİN.KALEAĞASI ŞÜKRÜ HAKAN,MERTSOYLU HÜSEYİN, ÖZYILKAN ÖZGÜR.Muhammad Wasif Saif - Severe Pulmonary Toxicity Associated with Fludarabine and Possible Contribution of Rituximab.
Chemotherapy, 56(2), 89- 93., Citation Count: 5, Doi: 10.1159/000305255, DİŞEL UMUT.PAYDAŞ SEMRA,YAVUZ SİNAN,KARAKOÇ EMRE
